SGLT2 inhibitors (flozins)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SGLT2 inhibitors (flozins), covering 2025-11-19 to 2025-11-19. Get the full timeline:
Most recent: Clinical Trial Update: Cardiovascular and Renal Endpoints With Flozins - an Observational Prospective Study in CKD HFpEF Patients